Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF7L2 | hg38_v1_chr10_+_113125536_113125665 | -0.24 | 1.8e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.4 | 5.8 | GO:1903631 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
0.3 | 4.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 4.6 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.9 | 4.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.2 | 3.9 | GO:0070141 | Leydig cell differentiation(GO:0033327) positive regulation of mammary gland epithelial cell proliferation(GO:0033601) response to UV-A(GO:0070141) |
1.2 | 3.5 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.2 | 3.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.6 | 3.0 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.2 | 3.0 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 4.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 3.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 3.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.9 | 3.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 3.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 3.2 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 3.0 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 2.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 2.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 8.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 8.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.4 | 5.8 | GO:0004341 | gluconolactonase activity(GO:0004341) |
0.9 | 4.3 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.0 | 4.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 3.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 3.9 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 3.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 3.3 | GO:0001848 | complement binding(GO:0001848) |
0.5 | 3.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 5.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 3.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 2.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 2.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 4.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 4.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 3.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 3.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 3.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 3.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 2.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |